was read the article
array:24 [ "pii" => "S2173580814001321" "issn" => "21735808" "doi" => "10.1016/j.nrleng.2012.04.021" "estado" => "S300" "fechaPublicacion" => "2014-11-01" "aid" => "385" "copyright" => "Sociedad Española de Neurología" "copyrightAnyo" => "2012" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "ssu" "cita" => "Neurologia. 2014;29:533-40" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3663 "formatos" => array:3 [ "EPUB" => 51 "HTML" => 2351 "PDF" => 1261 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0213485312001363" "issn" => "02134853" "doi" => "10.1016/j.nrl.2012.04.015" "estado" => "S300" "fechaPublicacion" => "2014-11-01" "aid" => "385" "copyright" => "Sociedad Española de Neurología" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "ssu" "cita" => "Neurologia. 2014;29:533-40" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 46241 "formatos" => array:3 [ "EPUB" => 87 "HTML" => 42239 "PDF" => 3915 ] ] "es" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Revisión</span>" "titulo" => "Cefalea de elevada altitud y mal de altura" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "533" "paginaFinal" => "540" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "High-altitude headache and acute mountain sickness" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F.J. Carod-Artal" "autores" => array:1 [ 0 => array:2 [ "nombre" => "F.J." "apellidos" => "Carod-Artal" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173580814001321" "doi" => "10.1016/j.nrleng.2012.04.021" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580814001321?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213485312001363?idApp=UINPBA00004N" "url" => "/02134853/0000002900000009/v1_201411120045/S0213485312001363/v1_201411120045/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173580814001394" "issn" => "21735808" "doi" => "10.1016/j.nrleng.2012.04.022" "estado" => "S300" "fechaPublicacion" => "2014-11-01" "aid" => "370" "copyright" => "Sociedad Española de Neurología" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "ssu" "cita" => "Neurologia. 2014;29:541-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 4290 "formatos" => array:3 [ "EPUB" => 63 "HTML" => 2535 "PDF" => 1692 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "Parkinson's disease and Alzheimer disease: environmental risk factors" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "541" "paginaFinal" => "549" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Enfermedad de Parkinson y enfermedad de Alzheimer: factores de riesgo ambientales" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Campdelacreu" "autores" => array:1 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Campdelacreu" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0213485312001090" "doi" => "10.1016/j.nrl.2012.04.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213485312001090?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580814001394?idApp=UINPBA00004N" "url" => "/21735808/0000002900000009/v1_201411150342/S2173580814001394/v1_201411150342/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173580814001333" "issn" => "21735808" "doi" => "10.1016/j.nrleng.2012.05.009" "estado" => "S300" "fechaPublicacion" => "2014-11-01" "aid" => "392" "copyright" => "Sociedad Española de Neurología" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "ssu" "cita" => "Neurologia. 2014;29:523-32" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 4328 "formatos" => array:3 [ "EPUB" => 56 "HTML" => 3110 "PDF" => 1162 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "Inappropriate treatments for patients with cognitive decline" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "523" "paginaFinal" => "532" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Prescripciones inconvenientes en el tratamiento del paciente con deterioro cognitivo" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Robles Bayón, F. Gude Sampedro" "autores" => array:2 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Robles Bayón" ] 1 => array:2 [ "nombre" => "F." "apellidos" => "Gude Sampedro" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0213485312001855" "doi" => "10.1016/j.nrl.2012.05.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213485312001855?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580814001333?idApp=UINPBA00004N" "url" => "/21735808/0000002900000009/v1_201411150342/S2173580814001333/v1_201411150342/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review article</span>" "titulo" => "High-altitude headache and acute mountain sickness" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "533" "paginaFinal" => "540" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "F.J. Carod-Artal" "autores" => array:1 [ 0 => array:3 [ "nombre" => "F.J." "apellidos" => "Carod-Artal" "email" => array:1 [ 0 => "fjcarod-artal@hotmail.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Neurología, Hospital Virgen de la Luz, Cuenca, Spain" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Cefalea de elevada altitud y mal de altura" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The first written record about high-altitude headache dates back to 30 BCE and is owed to Too Kin, an officer of the Imperial Chinese Army. Too Kin, along with his troops, experienced an episode of altitude sickness in a mountain range in Afghanistan which he named the Great Headache Mountain and the Little Headache Mountain.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Two millennia went by before Paul Bert, the chair of physiology at the Sorbonne after Claude Bernard, developed the modern discipline of altitude physiology.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> In 1913, Thomas Ravenhill provided the first clinical descriptions of signs and symptoms associated with rapid ascent to high altitude in the north of Chile, and reported on both high-altitude cerebral oedema and high-altitude pulmonary oedema.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Headache is the most common complication of exposure to high altitude, and it can appear as isolated high-altitude headache (HAH) or in conjunction with acute mountain sickness (AMS). HAH is a global health problem whose incidence has increased over the past decades due to different factors. These include more opportunities for travel, exercise, and tourism which therefore expose thousands of tourists, travellers and sports enthusiasts to a rapid increase in altitude, frequently with no previous acclimation.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Exposure to altitude is considered high for subjects at elevations of 1500 to 3700<span class="elsevierStyleHsp" style=""></span>m above sea level, very high at 3700 to 5500<span class="elsevierStyleHsp" style=""></span>m, and extreme above 5500<span class="elsevierStyleHsp" style=""></span>m.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">However, a person with high altitude exposure can experience different types of headaches in addition to headache associated with altitude. This being the case, episodic migraine crises precipitated by hypoxia and altitude, as well as headache linked to acute mountain sickness, must be considered. The purpose of this article is to review several aspects related to diagnosis and treatment of HAH and AMS. To this end, we searched the Medline database for all articles published in English or Spanish up to February 2012, using the keywords ‘headache altitude’ and ‘acute mountain sickness’.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">High-altitude headache</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Epidemiology</span><p id="par0020" class="elsevierStylePara elsevierViewall">It is estimated that at least 25% of non-acclimated individuals exposed to altitudes of 1859 to 2750<span class="elsevierStyleHsp" style=""></span>m experience high-altitude headache. At altitudes above 3000<span class="elsevierStyleHsp" style=""></span>m, 80% of individuals will have HAH and almost 100% will experience headache at 4500<span class="elsevierStyleHsp" style=""></span>m or higher.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Definition, clinical presentation and risk factors</span><p id="par0025" class="elsevierStylePara elsevierViewall">The second edition of the International Classification of Headache Disorders (ICHD-II)<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> includes high-altitude headache (subsection 10.1.1) in chapter 10 (Headache attributed to disorder of homoeostasis), section 10.1 (Headache attributed to hypoxia and/or hypercapnia). Diagnostic criteria are listed in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">HAH can appear as an isolated symptom within the first 24<span class="elsevierStyleHsp" style=""></span>hours of exposure to altitudes above 2500<span class="elsevierStyleHsp" style=""></span>m without previous acclimation, or it may present along with more varied signs and symptoms which constitute AMS, as we will discuss in a later section.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">HAH has a mild to moderate intensity and can be described as bilateral dull or pressing pain in the frontal, frontoparietal, or holocranial regions.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,9</span></a> Clinically, this headache is usually aggravated by exertion and head or body movement. It may also present with throbbing pain which, according to different studies, affects 30%<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> to 75%<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> of individuals. Headaches either begin upon awakening, or wake subjects at night, in at least 25% of the cases. This type of headache seems to be more intense in women and in individuals with a history of other types of headache in daily life.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">The connection between HAH and episodic migraine is yet to be determined. As pain in HAH seems to be more intense in patients with a previous history of migraine, some authors hypothesise that it may be associated with migraine.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> Migraine without aura should be differentiated from HAH, especially in subjects with a prior history of migraine. It is believed that some cases of migraine with aura could be related to the presence of right-to-left shunt blood vessels that are increasingly active with physical exertion and altitude.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> Doctors have also described isolated cases of primary cluster headache triggered by exposure to high altitude and responding to oxygen therapy.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">Rapid ascent to a high altitude is the main risk factor.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7,12–14</span></a> Known risk factors for HAH are listed in <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>. According to a study comprising 506 mountaineers who experienced headache at altitudes of 2200 to 3817<span class="elsevierStyleHsp" style=""></span>m, risk factors for HAH were previous history of migraine, intense physical exertion, and low arterial oxygen saturation.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> Adults and the elderly have a lower incidence of headache than the younger population, which may be due to the effect of cerebral atrophy. A good level of physical fitness (‘being fit’) does not prevent HAH.</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Pathogenesis</span><p id="par0050" class="elsevierStylePara elsevierViewall">There is an inverse relationship between altitude/atmospheric pressure and PaO<span class="elsevierStyleInf">2</span>. Chemoreceptors in the carotid body of a person gaining altitude detect a reduction in PaO<span class="elsevierStyleInf">2</span>. Hypoxia promotes a neurohumoral and haemodynamic response that gives rise to increased capillary pressure and vascular and cerebral oedema. Hypoxia-induced cerebral vasodilation is a probable cause of headache. Cerebral blood flow is elevated in the hypoxic state and returns to pre-ascent values with acclimation.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">Cerebral autoregulation, a process aimed at regulating cerebral perfusion according to variations in blood pressure, is altered by hypoxia and in individuals suffering from HAH and AMS.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> Studies performed with transcranial Doppler, which measures velocity in the middle cerebral artery (MCA) as an indicator of cerebral blood flow, show considerable variations in flow velocity.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> Sea-level assessment of dynamic cerebral autoregulation, which uses transcranial Doppler to calculate velocity in the MCA, can act as a predictor for susceptibility to AMS.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a> A lower baseline autoregulation index may be considered a potential risk factor for AMS.</p><p id="par0060" class="elsevierStylePara elsevierViewall">However, researchers have also proposed other factors apart from hypobaric hypoxia that favour HAH, for example, alterations in the blood-brain barrier promoted by different mediators, such as vascular endothelial growth factor, nitric oxide, or bradykinin.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Some also suggest that the trigeminovascular system may be activated at high altitude by either chemical stimuli (nitric oxide) or mechanical stimuli (vasodilation).<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Diagnosis</span><p id="par0065" class="elsevierStylePara elsevierViewall">For HAH to be diagnosed, the condition must appear at altitudes above 2500<span class="elsevierStyleHsp" style=""></span>m and it may not be attributable to other causes. For this reason, differential diagnosis for HAH must consider an array of toxic and metabolic causes and space-occupying cerebral lesions listed in <a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>. The differential diagnosis commonly includes headache due to viral infections and dehydration.<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a></p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia></span></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Acute mountain sickness</span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Epidemiology</span><p id="par0070" class="elsevierStylePara elsevierViewall">Incidence of AMS is approximately 45% to 95%, depending on the series. It is estimated that almost 50% of trekkers ascending above 5000<span class="elsevierStyleHsp" style=""></span>m experience acute mountain sickness.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Acclimation</span><p id="par0075" class="elsevierStylePara elsevierViewall">Immediate physiological changes induced by hypoxia and altitude include increases in heart and respiratory rates, increased diuresis, alterations in taste perception, nasal congestion, and sometimes syncope. Acclimation can be considered the final stage of a process in which individuals adapt to altitude hypoxia. While acclimation takes several days to weeks, symptoms of AMS present at the onset of this process.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a></p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Symptoms</span><p id="par0080" class="elsevierStylePara elsevierViewall">The main symptom of AMS is headache, frequently accompanied by sleep disorders, fatigue, dizziness and instability, nausea, and anorexia. Insomnia is the second most frequent symptom and presents in at least 60% of all individuals reaching 3500<span class="elsevierStyleHsp" style=""></span>m. Non-restorative sleep may be secondary to periodic breathing that interrupts sleep architecture with a pattern of hypoxia-hyperventilation-hypocapnia; other factors such as headache and fatigue may also promote insomnia.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">21</span></a> High-altitude syncope seems to be a vasovagal phenomenon related to hypoxia, although at times the presence of arrhythmias may trigger it.<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">The frequency and intensity of symptoms associated with AMS seem to point to some degree of individual susceptibility and considerable inter-individual variability. For this reason it is believed that there may be a certain genetic predisposition to AMS. In any case, human response to hypobaric hypoxia seems to be polygenic<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a> and determined by different expression of genes encoding different proteins, such as serum erythropoietin, hypoxia-inducible factor 1alpha (HIF-1alpha), angiotensin-converting enzyme, aldosterone, and nitric oxide synthase activity, among others.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a></p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Pathophysiology</span><p id="par0090" class="elsevierStylePara elsevierViewall">From a pathophysiological point of view, the main pathogenetic factor in acute mountain sickness is hypobaric hypoxia, which can be exacerbated by hypoventilation, a periodic breathing pattern, and relatively intense physical exertion. The combination of these factors leads to an increase in capillary permeability, sodium retention, vasodilation, and an increase in cerebral blood flow and pulmonary hypertension.<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a></p><p id="par0095" class="elsevierStylePara elsevierViewall">Apart from O<span class="elsevierStyleInf">2</span> and CO<span class="elsevierStyleInf">2</span> concentrations, several factors can affect blood vessel tonicity in hypoxia, mainly cerebral adenosine, potassium ion, and nitric oxide synthase levels. Vascular permeability may be influenced not only by hypoxia but also by different chemical mediators, such as hypoxia-inducible factor 1 (HIF-1)<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">25</span></a> and vascular endothelial growth factor (VEGF).<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">26</span></a></p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Diagnosis</span><p id="par0100" class="elsevierStylePara elsevierViewall">The Lake Louise AMS scoring system was developed for establishing an early diagnosis and monitoring severity of AMS symptoms in individuals exposed to high altitudes.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">27</span></a> It consists of 2 sections, a self-reported questionnaire and a clinical assessment form. A diagnosis of AMS requires the presence of the main symptom, headache (even when it presents with mild intensity), plus at least 1 additional symptom.</p><p id="par0105" class="elsevierStylePara elsevierViewall">Diagnostic criteria for AMS by Lake Louise Consensus Group are listed in <a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>. Scores of 3 to 5 on the questionnaire indicate mild AMS and scores of 6 or more indicate severe AMS.<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">28</span></a> An adapted Spanish version of the Lake Louise AMS questionnaire was validated a few years ago.<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a> The Environmental Symptoms Questionnaire is a more detailed and time-consuming questionnaire that may be useful for assessing severity of AMS symptoms in applied research.<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">30</span></a></p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">High-altitude cerebral oedema</span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Epidemiology</span><p id="par0110" class="elsevierStylePara elsevierViewall">High-altitude cerebral oedema (HACE) is the most severe form of AMS. It may occur above 2500<span class="elsevierStyleHsp" style=""></span>m and should therefore be considered in differential diagnosis of HAH. HACE is a potentially highly severe encephalopathy that may affect 0.5% to 1% of all individuals suffering from AMS.<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">31</span></a> In addition, it is estimated that 5% of non-acclimated individuals may present cerebral oedema above 4500<span class="elsevierStyleHsp" style=""></span>m. The incidence of high-altitude pulmonary oedema is approximately 2%.<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">32</span></a></p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Symptoms</span><p id="par0115" class="elsevierStylePara elsevierViewall">The mildest forms of cerebral oedema present with headache, dizziness, vertigo, and reaction time retardation. The most severe forms can present with ataxia, altered level of consciousness, hallucinations, seizures, stupor, and coma. Above 7500<span class="elsevierStyleHsp" style=""></span>m, 32% of climbers experience hallucinations. An increase in intracranial pressure may lead to papilloedema, retinal haemorrhage and paralysis of cranial nerves, especially cranial nerve VI. The most severe forms may progress to cerebral herniation, and intracranial hypertension resulting in death.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">33</span></a> Retinal haemorrhages, which are frequent during high-altitude ascent, occur in 30% and 50% of individuals suffering from AMS and HACE, respectively.<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">34</span></a></p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Neuroimaging findings</span><p id="par0120" class="elsevierStylePara elsevierViewall">Neuroimaging studies (cerebral computed tomography and brain magnetic resonance imaging) showed small ventricles and cerebral sulci effacement in climbers suffering HACE. It is not yet known whether cerebral oedema is of vasogenic or cytotoxic origin, or whether one precedes the other or if both present simultaneously.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> Hypoxia may produce a generalised vasogenic oedema subsequent to an increase in blood-brain barrier permeability. However, both cytotoxic<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">35</span></a> and vasogenic<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">36</span></a> cellular oedema have been detected. Cytotoxic oedema may derive from disorders in ATP-dependent sodium-potassium pump functioning.</p><p id="par0125" class="elsevierStylePara elsevierViewall">Individuals suffering from high-altitude cerebral and pulmonary oedema showed hyperintense areas in the splenium of the corpus callosum and in the centrum semiovale, but no abnormalities in cortical grey matter.<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a> On this basis, many authors suggest that high-altitude cerebral oedema is predominantly a reversible vasogenic cerebral oedema in the white matter.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">36</span></a> Brain MRI has also shown hyperintensities in subcortical white matter in individuals above 7000<span class="elsevierStyleHsp" style=""></span>m.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">36</span></a></p><p id="par0130" class="elsevierStylePara elsevierViewall">Additional brain MRI studies in HACE patients revealed haemosiderin depositions, mostly in the corpus callosum.<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a></p></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Pathogenesis</span><p id="par0135" class="elsevierStylePara elsevierViewall">HACE pathogenesis has traditionally been based on the theory of intracranial hypertension secondary to hypobaric hypoxia. However, some authors have stated that correlation between headache in AMS and cerebral oedema is unclear.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> It has recently been suggested that hypoxia may affect not only cerebral blood flow, but also cause a certain degree of cerebral venous insufficiency. Thus, a slight increase in central venous pressure (as occurs with hypoxia-induced pulmonary vasoconstriction, for example) may compromise cerebral venous outflow at high altitudes and favour oedema.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">38</span></a> Cerebral oedema is considered the main factor leading to increased brain volume and intracranial hypertension. However, there are other mechanisms, such as increases in cerebral blood flow or venous outflow obstruction, which may also increase intracranial pressure.</p></span></span><span id="sec0145" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">Other neurological and neuropsychological complications associated with high altitude</span><p id="par0210" class="elsevierStylePara elsevierViewall">Cerebrovascular complications described in association with high altitude include transient ischaemic attack and ischaemic stroke. Their origin may be related to vasospasm and vasoconstriction phenomena favoured by the hypocapnia, severe dehydration, and thrombophilia associated with hypoxia.<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">39</span></a> Some cases of patients who died at high altitude due to cerebral venous thrombosis can be found in medical literature.<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">40</span></a> Histopathological and postmortem examinations have confirmed the presence of ring-shaped microhaemorrhages associated with cerebral venous thrombosis.<a class="elsevierStyleCrossRefs" href="#bib0120"><span class="elsevierStyleSup">24,40,41</span></a></p><p id="par0145" class="elsevierStylePara elsevierViewall">Exposure to hypobaric hypoxia leads to neuropsychological disturbances in perception, memory, language, reaction time, learning, and psychomotor skills. Learning capacity, short-term memory and spatial memory are affected at altitudes above 4500<span class="elsevierStyleHsp" style=""></span>m, and more profoundly at more than 6000<span class="elsevierStyleHsp" style=""></span>m. Symptom intensity varies according to ascent rate and altitude.<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">42,43</span></a></p></span><span id="sec0095" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0145">Treatment</span><span id="sec0100" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0150">High-altitude headache</span><p id="par0150" class="elsevierStylePara elsevierViewall">Pharmacological treatment in the acute phase must distinguish isolated headache in AMS from cerebral oedema. As HAH is frequently self-limited and remits in 2 or 3 days, climbers are recommended to stop climbing, rest, and rehydrate when the condition presents. If symptoms persist or worsen, climbers should descend 500 to 1000<span class="elsevierStyleHsp" style=""></span>m.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Adequate hydration, analgesics and anti-inflammatory agents may improve symptoms.<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a></p><p id="par0155" class="elsevierStylePara elsevierViewall">HAH can be treated with paracetamol (500-1000<span class="elsevierStyleHsp" style=""></span>mg) and anti-inflammatory agents such as ibuprofen (400-600<span class="elsevierStyleHsp" style=""></span>mg).<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">19,44</span></a> Triptans are not effective, although they can be useful for migraine associated with hypoxia. At extreme altitudes, supplementary oxygen (2-4<span class="elsevierStyleHsp" style=""></span>L/minute) may be necessary during the night.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> Once oxygen therapy has been administered, HAH should improve within about 15 minutes; this event may be an indicator for ruling out migraine.</p></span><span id="sec0105" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0155">Acute mountain sickness and cerebral oedema</span><p id="par0160" class="elsevierStylePara elsevierViewall">Pharmacological treatment of AMS is intended to increase ventilatory drive with drugs such as acetazolamide, and reduce inflammation and cytokine release by means of steroids.</p><p id="par0165" class="elsevierStylePara elsevierViewall">Acetazolamide is a carbonic anhydrase inhibitor that acts on the brain in addition to the blood cells, renal tubules, chemoreceptors, and systemic and pulmonary vessels. It provokes metabolic acidosis, thus increasing respiratory minute volume. Cerebral oedema can be treated with acetazolamide (125-250<span class="elsevierStyleHsp" style=""></span>mg every 8-12<span class="elsevierStyleHsp" style=""></span>h),<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">45</span></a> dexamethasone (4<span class="elsevierStyleHsp" style=""></span>mg/6<span class="elsevierStyleHsp" style=""></span>h, orally),<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">46</span></a> and/or portable hyperbaric chamber (193<span class="elsevierStyleHsp" style=""></span>mbar during 1<span class="elsevierStyleHsp" style=""></span>h),<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">47</span></a> depending on intensity and severity of symptoms.<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">48</span></a> Dexamethasone seems to block VEGF expression and reverts hypoxia-induced cerebral oedema.<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">49</span></a></p></span></span><span id="sec0135" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0160">Prevention</span><span id="sec0140" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0165">High-altitude headache</span><p id="par0170" class="elsevierStylePara elsevierViewall">A slow ascent which promotes acclimation is recommended. At 2500<span class="elsevierStyleHsp" style=""></span>m and above, the maximum advisable ascent rate would be approximately 600<span class="elsevierStyleHsp" style=""></span>m per day. This may reduce the incidence of AMS by 40%. Diet is also important and should be based on carbohydrates. Alcohol should be avoided.</p><p id="par0175" class="elsevierStylePara elsevierViewall">Results from the HEAT trial (Headache Evaluation at Altitude Trial) were published recently; this clinical trial compared the effects of 600<span class="elsevierStyleHsp" style=""></span>mg ibuprofen or 85<span class="elsevierStyleHsp" style=""></span>mg acetazolamide or placebo for preventing HAH in 343 healthy subjects at 4300<span class="elsevierStyleHsp" style=""></span>m.<a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">50</span></a> Headache incidence rates were similar in participants treated with acetazolamide (27.1%) or ibuprofen (27.5%), and both were lower than that among participants receiving the placebo (45.3%). This suggests that both drugs in such doses are equally efficacious against HAH.<a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">50</span></a></p></span><span id="sec0120" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0170">Acute mountain sickness</span><p id="par0180" class="elsevierStylePara elsevierViewall">Individuals ascending above 3000<span class="elsevierStyleHsp" style=""></span>m or with a previous history of AMS-associated headache are recommended to take acetazolamide as preventive treatment. The recommended preventive dosage is 125 to 250<span class="elsevierStyleHsp" style=""></span>mg every 12<span class="elsevierStyleHsp" style=""></span>hours, at least 24<span class="elsevierStyleHsp" style=""></span>hours before ascent and for 2 days while the subject is at high altitude.<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">48,51</span></a> Higher doses (375<span class="elsevierStyleHsp" style=""></span>mg every 12<span class="elsevierStyleHsp" style=""></span>hours) do not seem to be more efficacious than a dose of 125<span class="elsevierStyleHsp" style=""></span>mg every 12<span class="elsevierStyleHsp" style=""></span>hours.<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">52</span></a> However, results from the SPACE trial (spironolactone and acetazolamide trial in the prevention of acute mountain sickness) showed that spironolactone does not seem to prevent AMS compared to results from acetazolamide.<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">53</span></a></p><p id="par0185" class="elsevierStylePara elsevierViewall">Dexamethasone (8<span class="elsevierStyleHsp" style=""></span>mg per day, administered in several doses) is effective for preventing AMS because it reduces cytokine-release and capillary permeability.<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">54</span></a> Prednisolone at a dose of 20<span class="elsevierStyleHsp" style=""></span>mg every 24<span class="elsevierStyleHsp" style=""></span>hours for 2 days before ascent and 3 days while at high altitude is also beneficial.<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">55</span></a></p><p id="par0190" class="elsevierStylePara elsevierViewall">Ginkgo biloba extracts have been used to promote free radical elimination and prevent AMS. However, the PHAIT trial (prevention of high altitude illness trial) showed that it does not seem to be efficacious for preventing AMS compared to results from acetazolamide.<a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">56</span></a> Aspirin, at a dose of 325<span class="elsevierStyleHsp" style=""></span>mg three times daily, seems to reduce the incidence of headache associated with physical exertion at high altitude.<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">57</span></a> Different recommendations on preventive measures for HAH, are listed in <a class="elsevierStyleCrossRef" href="#tbl0025">Table 5</a> according to level of evidence.</p><elsevierMultimedia ident="tbl0025"></elsevierMultimedia><p id="par0195" class="elsevierStylePara elsevierViewall">We need new clinical trials to confirm whether sumatriptan, dosed at 50<span class="elsevierStyleHsp" style=""></span>mg before ascent, is efficacious for preventing AMS.<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">58</span></a> Additional trials will have to confirm the results of a small study that found that low doses of theophylline (300<span class="elsevierStyleHsp" style=""></span>mg per day for 5 days) were efficacious for preventing AMS.<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">59</span></a></p></span></span><span id="sec0125" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0175">Conclusion</span><p id="par0200" class="elsevierStylePara elsevierViewall">HAH can occur in isolation or as the main symptom of AMS. In any case, clinical symptoms seem to display a progressive pattern along the continuum of HAH, AMS, and HACE. At present, the recent discoveries of different chemical mediators provide us with a better understanding of the pathogenesis of this continuum and of the therapeutic targets acted upon by acetazolamide and steroids.</p></span><span id="sec0130" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0180">Conflicts of interest</span><p id="par0205" class="elsevierStylePara elsevierViewall">The author has no conflicts of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:14 [ 0 => array:2 [ "identificador" => "xres382747" "titulo" => array:4 [ 0 => "Abstract" 1 => "Introduction" 2 => "Development" 3 => "Conclusions" ] ] 1 => array:2 [ "identificador" => "xpalclavsec361647" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "xres382748" "titulo" => array:4 [ 0 => "Resumen" 1 => "Introducción" 2 => "Desarrollo" 3 => "Conclusiones" ] ] 3 => array:2 [ "identificador" => "xpalclavsec361648" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "High-altitude headache" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Epidemiology" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Definition, clinical presentation and risk factors" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Pathogenesis" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Diagnosis" ] ] ] 6 => array:3 [ "identificador" => "sec0035" "titulo" => "Acute mountain sickness" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0040" "titulo" => "Epidemiology" ] 1 => array:2 [ "identificador" => "sec0045" "titulo" => "Acclimation" ] 2 => array:2 [ "identificador" => "sec0050" "titulo" => "Symptoms" ] 3 => array:2 [ "identificador" => "sec0055" "titulo" => "Pathophysiology" ] 4 => array:2 [ "identificador" => "sec0060" "titulo" => "Diagnosis" ] ] ] 7 => array:3 [ "identificador" => "sec0065" "titulo" => "High-altitude cerebral oedema" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0070" "titulo" => "Epidemiology" ] 1 => array:2 [ "identificador" => "sec0075" "titulo" => "Symptoms" ] 2 => array:2 [ "identificador" => "sec0080" "titulo" => "Neuroimaging findings" ] 3 => array:2 [ "identificador" => "sec0085" "titulo" => "Pathogenesis" ] ] ] 8 => array:2 [ "identificador" => "sec0145" "titulo" => "Other neurological and neuropsychological complications associated with high altitude" ] 9 => array:3 [ "identificador" => "sec0095" "titulo" => "Treatment" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0100" "titulo" => "High-altitude headache" ] 1 => array:2 [ "identificador" => "sec0105" "titulo" => "Acute mountain sickness and cerebral oedema" ] ] ] 10 => array:3 [ "identificador" => "sec0135" "titulo" => "Prevention" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0140" "titulo" => "High-altitude headache" ] 1 => array:2 [ "identificador" => "sec0120" "titulo" => "Acute mountain sickness" ] ] ] 11 => array:2 [ "identificador" => "sec0125" "titulo" => "Conclusion" ] 12 => array:2 [ "identificador" => "sec0130" "titulo" => "Conflicts of interest" ] 13 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2012-03-12" "fechaAceptado" => "2012-04-21" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec361647" "palabras" => array:6 [ 0 => "Altitude" 1 => "Acetazolamide" 2 => "Headache" 3 => "Lake Louise Questionnaire" 4 => "Cerebral oedema" 5 => "Acute mountain sickness" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec361648" "palabras" => array:6 [ 0 => "Altitud" 1 => "Acetazolamida" 2 => "Cefalea" 3 => "Cuestionario Lago Louise" 4 => "Edema cerebral de altitud" 5 => "Mal de altura" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Headache is the most common complication associated with exposure to high altitude, and can appear as an isolated high-altitude headache (HAH) or in conjunction with acute mountain sickness (AMS). The purpose of this article is to review several aspects related to diagnosis and treatment of HAH.</p> <span class="elsevierStyleSectionTitle" id="sect0015">Development</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">HAH occurs in 80% of all individuals at altitudes higher than 3000<span class="elsevierStyleHsp" style=""></span>m. The second edition of ICHD-II includes HAH in the chapter entitled “Headaches attributed to disorder of homeostasis”. Hypoxia elicits a neurohumoral and haemodynamic response that may provoke increased capillary pressure and oedema. Hypoxia-induced cerebral vasodilation is a probable cause of HAH. The main symptom of AMS is headache, frequently accompanied by sleep disorders, fatigue, dizziness and instability, nausea and anorexia. Some degree of individual susceptibility and considerable inter-individual variability seem to be present in AMS. High-altitude cerebral oedema is the most severe form of AMS, and may occur above 2500<span class="elsevierStyleHsp" style=""></span>m. Brain MRI studies have found variable degrees of oedema in subcortical white matter and the splenium of the corpus callosum. HAH can be treated with paracetamol or ibuprofen. Pharmacological treatment of AMS is intended to increase ventilatory drive with drugs such as acetazolamide, and reduce inflammation and cytokine release by means of steroids.</p> <span class="elsevierStyleSectionTitle" id="sect0020">Conclusions</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Symptom escalation seems to be present along the continuum containing HAH, AMS, and high-altitude cerebral oedema.</p>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span class="elsevierStyleSectionTitle" id="sect0030">Introducción</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">La cefalea es la complicación más frecuente de la exposición a la altitud y puede aparecer de forma aislada o bien asociada al mal de altura (MA). El objetivo de este artículo es revisar los aspectos relacionados con el diagnóstico y tratamiento de la cefalea de elevada altitud (CEA).</p> <span class="elsevierStyleSectionTitle" id="sect0035">Desarrollo</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">El 80% de las personas presentan CEA por encima de los 3.000<span class="elsevierStyleHsp" style=""></span>m de altitud. La segunda versión de la <span class="elsevierStyleItalic">Internacional Classification of Headache Disorders</span> (ICHD-II) incluye la CEA en el capítulo «Cefalea atribuida a trastornos de la homeostasia». La hipoxia desencadena una respuesta neurohumoral y hemodinámica que provoca un aumento de la presión capilar y edema. La vasodilatación cerebral inducida por hipoxia es una causa probable de CEA. El síntoma cardinal del MA es la cefalea, que se suele asociar con trastornos del sueño, fatiga, mareo e inestabilidad, náuseas y anorexia. Parece existir una cierta susceptibilidad así como una gran variación interindividual. La forma más grave es el edema cerebral de altitud y puede suceder por encima de los 2.500<span class="elsevierStyleHsp" style=""></span>m. Estudios de resonancia de encéfalo han mostrado la presencia de edema en sustancia blanca y esplenio del cuerpo calloso. La CEA puede tratarse con paracetamol e ibuprofeno. El tratamiento farmacológico del MA tiene la finalidad de incrementar la respuesta ventilatoria, mediante fármacos como la acetazolamida, y reducir los procesos inflamatorios y de liberación de citocinas, mediante el empleo de esteroides.</p> <span class="elsevierStyleSectionTitle" id="sect0040">Conclusiones</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Parece haber una progresión en la expresión de los síntomas entre la CEA, el MA y el edema cerebral de altitud.</p>" ] ] "NotaPie" => array:2 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Carod-Artal FJ. Cefalea de elevada altitud y mal de altura. Neurología. 2014;29:533–540.</p>" ] 1 => array:2 [ "etiqueta" => "☆☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">This study was presented as a lecture to the Headache Study Group at the 63rd Annual Meeting of the Spanish Society of Neurology, November 2011, Barcelona.</p>" ] ] "multimedia" => array:5 [ 0 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">A. Headache must present with at least 2 of the following characteristics and fulfil criteria C and D: \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>1. Bilateral \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>2. Frontal or frontotemporal \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>3. Dull or pressing pain \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>4. Mild to moderate intensity \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>5. Aggravated by exertion, movement, straining, coughing, or bending down \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">B. Ascent to altitudes above 2500<span class="elsevierStyleHsp" style=""></span>m \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">C. Headache develops within 24<span class="elsevierStyleHsp" style=""></span>hours after ascent \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">D. Headache resolves within 8<span class="elsevierStyleHsp" style=""></span>hours after descent \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab584436.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Diagnostic criteria for HAH</p>" ] ] 1 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">masl: metres above sea level.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Altitude reached \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Sleeping at high altitude \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Individual susceptibility \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Rate and mode of ascent \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Prior history of AMS \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Residence below 900<span class="elsevierStyleHsp" style=""></span>masl \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Intense exertion \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Dehydration \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Obesity \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Age (young people) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">History of cardiopulmonary disease \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab584435.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Risk factors for HAH</p>" ] ] 2 => array:7 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cerebral oedema/severe AMS \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hypoxia-/hypobaria-induced migraine \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Headache secondary to viral process \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Effects associated with alcohol, addictive drugs, and toxic chemicals \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Carbon monoxide poisoning \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Brain tumour \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Arteriovenous malformations \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">CNS infection \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Dehydration \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Metabolic disorders \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Diabetic ketoacidosis \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Hypothermia \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Hyponatraemia/hypoglycaemia \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab584434.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Differential diagnosis for HAH</p>" ] ] 3 => array:7 [ "identificador" => "tbl0020" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">masl: metres above sea level.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Headache in non-acclimated individuals who ascend rapidly to an altitude above 2500<span class="elsevierStyleHsp" style=""></span>m, and at least 1 of the following symptoms: \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>- Gastrointestinal: anorexia, nausea and vomiting \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>- Insomnia \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>- Dizziness/vertigo \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>- Fatigue \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>- Onset within 6-24<span class="elsevierStyleHsp" style=""></span>hours after ascent, sometimes within the first hour \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab584432.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Lake Louise diagnostic criteria for AMS</p>" ] ] 4 => array:7 [ "identificador" => "tbl0025" "etiqueta" => "Table 5" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">masl: metres above sea level.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Procedure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Dose \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Evidence \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Recommendations \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Slow ascent \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><300<span class="elsevierStyleHsp" style=""></span>masl \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">A \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Acetazolamide \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">250<span class="elsevierStyleHsp" style=""></span>mg to 1<span class="elsevierStyleHsp" style=""></span>g \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">A \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Dexamethasone \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8<span class="elsevierStyleHsp" style=""></span>mg/d \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">A \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Supplementary O<span class="elsevierStyleInf">2</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2<span class="elsevierStyleHsp" style=""></span>L/min \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">A \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Theophylline \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">375<span class="elsevierStyleHsp" style=""></span>mg/12<span class="elsevierStyleHsp" style=""></span>h \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">B \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Sumatriptan \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">50<span class="elsevierStyleHsp" style=""></span>mg \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">B \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Carbohydrate-rich diet \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">C \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Ginkgo biloba</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">240<span class="elsevierStyleHsp" style=""></span>mg/d \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">C \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab584433.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Recommended preventive measures for HAH according to the level of evidence</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:59 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The great breathlessness mountains" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "D. Rennie" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Med Assoc" "fecha" => "1986" "volumen" => "256" "paginaInicial" => "81" "paginaFinal" => "82" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "La pression barometrique" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "P. Bert" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:3 [ "fecha" => "1878" "editorial" => "G Masson" "editorialLocalizacion" => "Paris" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Some experiences of mountain sickness in the Andes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "T.H. Ravenhill" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Trop Med Hyg" "fecha" => "1913" "volumen" => "16" "paginaInicial" => "313" "paginaFinal" => "320" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The cerebral effects of ascent to high altitudes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.H. Wilson" 1 => "S. Newman" 2 => "C.H. Imray" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1474-4422(09)70014-6" "Revista" => array:6 [ "tituloSerie" => "Lancet Neurol" "fecha" => "2009" "volumen" => "8" "paginaInicial" => "175" "paginaFinal" => "191" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19161909" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High-altitude illness" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "P.H. Hackett" 1 => "R.C. Roach" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM200107123450206" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2001" "volumen" => "345" "paginaInicial" => "107" "paginaFinal" => "114" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11450659" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The International Classification of Headache Disorders, 2nd edition" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "Headache Classification Subcommittee of the International Headache Society" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Cephalalgia" "fecha" => "2004" "volumen" => "24" "numero" => "Suppl. 1" "paginaInicial" => "S9" "paginaFinal" => "S151" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute mountain sickness: pathophysiology, prevention, and treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C. Imray" 1 => "A. Wright" 2 => "A. Subudhi" 3 => "R. Roach" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.pcad.2010.02.003" "Revista" => array:6 [ "tituloSerie" => "Prog Cardiovasc Dis" "fecha" => "2010" "volumen" => "52" "paginaInicial" => "467" "paginaFinal" => "484" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20417340" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical features of headache at altitude: a prospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "E. Silber" 1 => "P. Sonnenberg" 2 => "D.J. Collier" 3 => "A.J. Pollar" 4 => "D.R. Murdoch" 5 => "P.J. Goadsby" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2003" "volumen" => "60" "paginaInicial" => "1167" "paginaFinal" => "1171" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12682326" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High altitude headache. A prospective study of its clinical characteristics" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M. Serrano Dueñas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-2982.2005.00968.x" "Revista" => array:6 [ "tituloSerie" => "Cephalalgia" "fecha" => "2005" "volumen" => "25" "paginaInicial" => "1110" "paginaFinal" => "1116" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16305599" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intrapulmonary and intracardiac shunting with exercise at altitude" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.H. Imray" 1 => "K.T. Pattinson" 2 => "S. Myers" 3 => "C.W. Chan" 4 => "H. Hoar" 5 => "S. Brearey" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1580/07-WEME-BR-162.1" "Revista" => array:6 [ "tituloSerie" => "Wilderness Environ Med" "fecha" => "2008" "volumen" => "19" "paginaInicial" => "199" "paginaFinal" => "204" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18715120" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of oxygen inhalation in sumatriptan refractory “high altitude” cluster headache attacks" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "E. Mampreso" 1 => "F. Maggioni" 2 => "F. Viaro" 3 => "C. Disco" 4 => "G. Zanchin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10194-009-0160-0" "Revista" => array:6 [ "tituloSerie" => "J Headache Pain" "fecha" => "2009" "volumen" => "10" "paginaInicial" => "465" "paginaFinal" => "467" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19779957" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Determinants of acute mountain sickness and success on Mount Aconcagua (6962<span class="elsevierStyleHsp" style=""></span>m)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Pesce" 1 => "C. Leal" 2 => "H. Pinto" 3 => "G. González" 4 => "M. Maggiorini" 5 => "M. Schneider" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/ham.2005.6.158" "Revista" => array:6 [ "tituloSerie" => "High Alt Med Biol" "fecha" => "2005" "volumen" => "6" "paginaInicial" => "158" "paginaFinal" => "166" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16060850" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Identifying the possible risk factors for high-altitude headache in mountaineers" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.S. Lawley" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0333102411422385" "Revista" => array:6 [ "tituloSerie" => "Cephalalgia" "fecha" => "2011" "volumen" => "31" "paginaInicial" => "1677" "paginaFinal" => "1678" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21926157" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors for high-altitude headache in mountaineers" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M. Burtscher" 1 => "K. Mairer" 2 => "M. Wille" 3 => "G. Broessner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0333102410394678" "Revista" => array:6 [ "tituloSerie" => "Cephalalgia" "fecha" => "2011" "volumen" => "31" "paginaInicial" => "706" "paginaFinal" => "711" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21220379" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of high altitude exposure on cerebral hemodynamics in normal subjects" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Van Osta" 1 => "J.J. Moraine" 2 => "C. Mélot" 3 => "H. Mairbäurl" 4 => "M. Maggiorini" 5 => "R. Naeije" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/01.STR.0000155735.85888.13" "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "2005" "volumen" => "36" "paginaInicial" => "557" "paginaFinal" => "560" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15692117" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cerebral artery dilatation maintains cerebral oxygenation at extreme altitude and in acute hypoxia – an ultrasound and MRI study" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Caudwell Xtreme Everest Research Group" "etal" => true "autores" => array:6 [ 0 => "M.H. Wilson" 1 => "M.E. Edsell" 2 => "I. Davagnanam" 3 => "S.P. Hirani" 4 => "D.S. Martin" 5 => "D.Z. Levett" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/jcbfm.2011.81" "Revista" => array:6 [ "tituloSerie" => "J Cereb Blood Flow Metab" "fecha" => "2011" "volumen" => "31" "paginaInicial" => "2019" "paginaFinal" => "2029" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21654697" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sea-level assessment of dynamic cerebral autoregulation predicts susceptibility to acute mountain sickness at high altitude" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N.J. Cochand" 1 => "M. Wild" 2 => "J.V. Brugniaux" 3 => "P.J. Davies" 4 => "K.A. Evans" 5 => "R.G. Wise" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/STROKEAHA.111.621714" "Revista" => array:6 [ "tituloSerie" => "Stroke" "fecha" => "2011" "volumen" => "42" "paginaInicial" => "3628" "paginaFinal" => "3630" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21960569" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High altitude headache. Lessons from headaches at sea level" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M. Sanchez del Rio" 1 => "M.A. Moskowitz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Adv Exp Med Biol" "fecha" => "1999" "volumen" => "474" "paginaInicial" => "145" "paginaFinal" => "153" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10634999" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High-altitude headache" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "L.P. Queiroz" 1 => "A.M. Rapoport" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Curr Pain Headache Rep" "fecha" => "2007" "volumen" => "11" "paginaInicial" => "293" "paginaFinal" => "296" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17686393" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute mountain sickness and ascent rates in trekkers above 2500<span class="elsevierStyleHsp" style=""></span>m in the Nepali Himalaya" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Vardy" 1 => "K. Judge" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aviat Space Environ Med" "fecha" => "2006" "volumen" => "77" "paginaInicial" => "742" "paginaFinal" => "744" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16856361" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Medicine at high altitude" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Birmingham Medical Research Expeditionary Society" "etal" => false "autores" => array:1 [ 0 => "A.D. Wright" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Med" "fecha" => "2006" "volumen" => "6" "paginaInicial" => "604" "paginaFinal" => "608" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17228562" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High altitude arrhythmias" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.R. Woods" 1 => "S. Allen" 2 => "T.R. Betts" 3 => "D. Gardiner" 4 => "H. Montgomery" 5 => "J.M. Morgan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000127445" "Revista" => array:6 [ "tituloSerie" => "Cardiology" "fecha" => "2008" "volumen" => "111" "paginaInicial" => "239" "paginaFinal" => "246" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18434732" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genetic variation in hypoxia inducible factor 1alpha and its possible association with high altitude adaptation in Sherpas" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K. Suzuki" 1 => "T. Kizaki" 2 => "Y. Hitomi" 3 => "M. Nukita" 4 => "K. Kimoto" 5 => "N. Miyazawa" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Med Hypotheses" "fecha" => "2003" "volumen" => "61" "paginaInicial" => "385" "paginaFinal" => "389" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12944107" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute mountain sickness: medical problems associated with acute and subacute exposure to hypobaric hypoxia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "C. Clarke" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/pgmj.2006.047662" "Revista" => array:6 [ "tituloSerie" => "Postgrad Med J" "fecha" => "2006" "volumen" => "82" "paginaInicial" => "748" "paginaFinal" => "753" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17099095" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Yamakawa" 1 => "L.X. Liu" 2 => "T. Date" 3 => "A.J. Belanger" 4 => "K.A. Vincent" 5 => "G.Y. Akita" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/01.RES.0000093984.48643.D7" "Revista" => array:6 [ "tituloSerie" => "Circ Res" "fecha" => "2003" "volumen" => "93" "paginaInicial" => "664" "paginaFinal" => "673" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12958144" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hypothesis: angiogenesis cytokines in high altitude cerebral oedema" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.W. Severinghaus" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acta Anaesthesiol Scand Suppl" "fecha" => "1995" "volumen" => "107" "paginaInicial" => "177" "paginaFinal" => "178" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8599273" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The Lake Louise Acute Mountain Sickness scoring system" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "The Lake Louise AMS Scoring Consensus Committee" "etal" => false "autores" => array:4 [ 0 => "R.C. Roach" 1 => "P. Bartsch" 2 => "P.H. Hackett" 3 => "O. Oelz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:4 [ "titulo" => "Hypoxia and molecular medicine" "paginaInicial" => "273" "paginaFinal" => "274" "serieFecha" => "1993" ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparing questionnaires for the assessment of acute mountain sickness" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "P. Dellasanta" 1 => "S. Gaillard" 2 => "L. Loutan" 3 => "B. Kayser" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/ham.2007.8305" "Revista" => array:6 [ "tituloSerie" => "High Alt Med Biol" "fecha" => "2007" "volumen" => "8" "paginaInicial" => "184" "paginaFinal" => "191" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17824818" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Propiedades métricas de la versión española del Cuestionario de Mal de Altura del Lago Louise" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "F.J. Carod-Artal" 1 => "D. Ezpeleta Echávarri" 2 => "A.L. Guerrero Peral" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nrl.2010.12.014" "Revista" => array:6 [ "tituloSerie" => "Neurología" "fecha" => "2011" "volumen" => "26" "paginaInicial" => "337" "paginaFinal" => "342" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21354668" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0150" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The environmental symptoms questionnaire: revisions and new field data" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.B. Sampson" 1 => "J.L. Kobrick" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aviat Space Environ Med" "fecha" => "1980" "volumen" => "51" "paginaInicial" => "872" "paginaFinal" => "877" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7417157" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0155" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Who should not go high: chronic disease and work at altitude during construction of the Qinghai-Tibet railroad" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T.Y. Wu" 1 => "S.Q. Ding" 2 => "J.L. Liu" 3 => "M.T. Yu" 4 => "J.H. Jia" 5 => "Z.C. Chai" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/ham.2007.1015" "Revista" => array:6 [ "tituloSerie" => "High Alt Med Biol" "fecha" => "2007" "volumen" => "8" "paginaInicial" => "88" "paginaFinal" => "107" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17584003" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0160" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence of high altitude illnesses among unacclimatized persons who acutely ascended to Tibet" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y. Ren" 1 => "Z. Fu" 2 => "W. Shen" 3 => "P. Jiang" 4 => "Y. He" 5 => "S. Peng" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/ham.2009.1049" "Revista" => array:6 [ "tituloSerie" => "High Alt Med Biol" "fecha" => "2010" "volumen" => "11" "paginaInicial" => "39" "paginaFinal" => "42" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20367487" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0165" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Altitude illness: risk factors, prevention, presentation, and treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D.C. Fiore" 1 => "S. Hall" 2 => "P. Shoja" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am Fam Physician" "fecha" => "2010" "volumen" => "82" "paginaInicial" => "1103" "paginaFinal" => "1110" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21121556" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0170" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High altitude cerebral edema" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "P.H. Hackett" 1 => "R.C. Roach" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/1527029041352054" "Revista" => array:6 [ "tituloSerie" => "High Alt Med Biol" "fecha" => "2004" "volumen" => "5" "paginaInicial" => "136" "paginaFinal" => "146" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15265335" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0175" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute sickness" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K. Kallenberg" 1 => "D.M. Bailey" 2 => "S. Christ" 3 => "A. Mohr" 4 => "R. Roukens" 5 => "E. Menold" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/sj.jcbfm.9600404" "Revista" => array:6 [ "tituloSerie" => "J Cereb Blood Flow Metab" "fecha" => "2007" "volumen" => "27" "paginaInicial" => "1064" "paginaFinal" => "1071" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17024110" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0180" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P.H. Hackett" 1 => "P.R. Yarnell" 2 => "R. Hill" 3 => "K. Reynard" 4 => "J. Heit" 5 => "J. McCormick" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Am Med Assoc" "fecha" => "1998" "volumen" => "280" "paginaInicial" => "1920" "paginaFinal" => "1925" ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0185" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microhemorrhages in nonfatal high-altitude cerebral edema" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K. Kallenberg" 1 => "C. Dehnert" 2 => "A. Dorfler" 3 => "P.D. Schellinger" 4 => "D.M. Bailey" 5 => "M. Knauth" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/jcbfm.2008.55" "Revista" => array:6 [ "tituloSerie" => "J Cereb Blood Flow Metab" "fecha" => "2008" "volumen" => "28" "paginaInicial" => "1635" "paginaFinal" => "1642" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18523438" "web" => "Medline" ] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0190" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The headache of high altitude and microgravity – similarities with clinical syndromes of cerebral venous hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.H. Wilson" 1 => "C.H. Imray" 2 => "A.R. Hargens" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/ham.2011.1026" "Revista" => array:6 [ "tituloSerie" => "High Alt Med Biol" "fecha" => "2011" "volumen" => "12" "paginaInicial" => "379" "paginaFinal" => "386" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22087727" "web" => "Medline" ] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0195" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Neurological conditions at altitude that fall outside the usual definition of altitude sickness" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B. Basnyat" 1 => "T. Wu" 2 => "J.H. Gertsch" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/1527029041352126" "Revista" => array:6 [ "tituloSerie" => "High Alt Med Biol" "fecha" => "2004" "volumen" => "5" "paginaInicial" => "171" "paginaFinal" => "179" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15265338" "web" => "Medline" ] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0200" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cerebral thrombosis at altitude: its pathogenesis and the problems of prevention and treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S.Y. Song" 1 => "T. Asaji" 2 => "Y. Tanizaki" 3 => "T. Fujimaki" 4 => "M. Matsutani" 5 => "R. Okeda" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aviat Space Environ Med" "fecha" => "1986" "volumen" => "57" "paginaInicial" => "71" "paginaFinal" => "76" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3942573" "web" => "Medline" ] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0205" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Altitude-related deaths in seven trekkers in the Himalayas" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J. Dickinson" 1 => "D. Health" 2 => "J. Gosney" 3 => "D. Williams" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Thorax" "fecha" => "1983" "volumen" => "38" "paginaInicial" => "646" "paginaFinal" => "656" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/6623417" "web" => "Medline" ] ] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0210" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Verbal free recall in high altitude: proper names vs common names" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G. Pelamatti" 1 => "M. Pascotto" 2 => "C. Semenza" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Cortex" "fecha" => "2003" "volumen" => "39" "paginaInicial" => "97" "paginaFinal" => "103" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12627756" "web" => "Medline" ] ] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0215" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cognition and metacognition at extreme altitudes on Mount Everest" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "T.O. Nelson" 1 => "J. Dunlosky" 2 => "D.M. White" 3 => "J. Steinberg" 4 => "B.D. Townes" 5 => "D. Anderson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Exp Psychol Gen" "fecha" => "1990" "volumen" => "119" "paginaInicial" => "367" "paginaFinal" => "374" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2148573" "web" => "Medline" ] ] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0220" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High altitude headache: efficacy of acetaminophen vs. ibuprofen in a randomized, controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "N.S. Harris" 1 => "R.P. Wenzel" 2 => "S.H. Thomas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Emerg Med" "fecha" => "2003" "volumen" => "24" "paginaInicial" => "383" "paginaFinal" => "387" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12745039" "web" => "Medline" ] ] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0225" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C.K. Grissom" 1 => "R.C. Roach" 2 => "F.H. Sarnquist" 3 => "P.H. Hackett" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "1992" "volumen" => "116" "paginaInicial" => "461" "paginaFinal" => "465" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1739236" "web" => "Medline" ] ] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0230" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dexamethasone for prevention and treatment of acute mountain sickness" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.H. Hackett" 1 => "R.C. Roach" 2 => "R.A. Wood" 3 => "R.G. Foutch" 4 => "R.T. Meehan" 5 => "D. Rennie" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aviat Space Environ Med" "fecha" => "1988" "volumen" => "59" "paginaInicial" => "950" "paginaFinal" => "954" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3190622" "web" => "Medline" ] ] ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0235" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of acute mountain sickness by simulated descent: a randomised controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P. Bärtsch" 1 => "B. Merki" 2 => "D. Hofstetter" 3 => "M. Maggiorini" 4 => "B. Kayser" 5 => "O. Oelz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Br Med J" "fecha" => "1993" "volumen" => "306" "paginaInicial" => "1098" "paginaFinal" => "1101" ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0240" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High hopes at high altitudes: pharmacotherapy for acute mountain sickness and high-altitude cerebral and pulmonary oedema" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Wright" 1 => "S. Brearey" 2 => "C. Imray" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1517/14656566.9.1.119" "Revista" => array:7 [ "tituloSerie" => "Expert Opin Pharmacother" "fecha" => "2008" "volumen" => "9" "paginaInicial" => "119" "paginaFinal" => "127" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18076343" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1873994611002510" "estado" => "S300" "issn" => "18739946" ] ] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib0245" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "H.J. Schoch" 1 => "S. Fischer" 2 => "H.H. Marti" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Brain" "fecha" => "2002" "volumen" => "125" "paginaInicial" => "2549" "paginaFinal" => "2557" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12390979" "web" => "Medline" ] ] ] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib0250" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.H. Gertsch" 1 => "G.S. Lipman" 2 => "P.S. Holck" 3 => "A. Merritt" 4 => "A. Mulcahy" 5 => "R.S. Fisher" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.wem.2010.06.009" "Revista" => array:6 [ "tituloSerie" => "Wilderness Environ Med" "fecha" => "2010" "volumen" => "21" "paginaInicial" => "236" "paginaFinal" => "243" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20832701" "web" => "Medline" ] ] ] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib0255" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "L. Dumont" 1 => "C. Mardirosoff" 2 => "M.R. Tramèr" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Br Med J" "fecha" => "2000" "volumen" => "321" "paginaInicial" => "267" "paginaFinal" => "277" ] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib0260" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acetazolamide 125<span class="elsevierStyleHsp" style=""></span>mg BD is not significantly different from 375<span class="elsevierStyleHsp" style=""></span>mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B. Basnyat" 1 => "J.H. Gertsch" 2 => "P.S. Holck" 3 => "E.W. Johnson" 4 => "A.M. Luks" 5 => "B.P. Donham" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/ham.2006.7.17" "Revista" => array:6 [ "tituloSerie" => "High Alt Med Biol" "fecha" => "2006" "volumen" => "7" "paginaInicial" => "17" "paginaFinal" => "27" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16544963" "web" => "Medline" ] ] ] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib0265" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group)" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "SPACE Trial Group" "etal" => true "autores" => array:6 [ 0 => "B. Basnyat" 1 => "P.S. Holck" 2 => "M. Pun" 3 => "S. Halverson" 4 => "P. Szawarski" 5 => "J. Gertsch" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.wem.2010.10.009" "Revista" => array:6 [ "tituloSerie" => "Wilderness Environ Med" "fecha" => "2011" "volumen" => "22" "paginaInicial" => "15" "paginaFinal" => "22" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21377114" "web" => "Medline" ] ] ] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib0270" "etiqueta" => "54" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevention of acute mountain sickness by dexamethasone" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "T.S. Johnson" 1 => "P.B. Rock" 2 => "C.S. Fulco" 3 => "L.A. Trad" 4 => "R.F. Spark" 5 => "J.T. Maher" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM198403153101103" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1984" "volumen" => "310" "paginaInicial" => "683" "paginaFinal" => "686" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/6700643" "web" => "Medline" ] ] ] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib0275" "etiqueta" => "55" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Glucocorticoids as prophylaxis against acute mountain sickness" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M. Basu" 1 => "R.C. Sawhney" 2 => "S. Kumar" 3 => "K. Pal" 4 => "R. Prasad" 5 => "W. Selvamurthy" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Endocrinol" "fecha" => "2002" "volumen" => "57" "paginaInicial" => "761" "paginaFinal" => "767" ] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib0280" "etiqueta" => "56" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J.H. Gertsch" 1 => "B. Basnyat" 2 => "E.W. Johnson" 3 => "J. Onopa" 4 => "P.S. Holck" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Br Med J" "fecha" => "2004" "volumen" => "328" "paginaInicial" => "797" ] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib0285" "etiqueta" => "57" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Aspirin for prophylaxis against headache at high altitudes: randomised, double blind, placebo controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M. Burtscher" 1 => "R. Likar" 2 => "W. Nachbauer" 3 => "M. Philadelphy" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Br Med J" "fecha" => "1998" "volumen" => "316" "paginaInicial" => "1057" "paginaFinal" => "1058" ] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib0290" "etiqueta" => "58" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sumatriptan for prevention of acute mountain sickness: randomized clinical trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S. Jafarian" 1 => "F. Gorouhi" 2 => "S. Salimi" 3 => "J. Lotfi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ana.21162" "Revista" => array:6 [ "tituloSerie" => "Ann Neurol" "fecha" => "2007" "volumen" => "62" "paginaInicial" => "273" "paginaFinal" => "277" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17557349" "web" => "Medline" ] ] ] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib0295" "etiqueta" => "59" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Low-dose theophylline reduces symptoms of acute mountain sickness" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "T.E. Küpper" 1 => "K.P. Strohl" 2 => "M. Hoefer" 3 => "U. Gieseler" 4 => "C.M. Netzer" 5 => "N.C. Netzer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1708-8305.2008.00228.x" "Revista" => array:6 [ "tituloSerie" => "J Travel Med" "fecha" => "2008" "volumen" => "15" "paginaInicial" => "307" "paginaFinal" => "314" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19006503" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735808/0000002900000009/v1_201411150342/S2173580814001321/v1_201411150342/en/main.assets" "Apartado" => array:4 [ "identificador" => "9423" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Review articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735808/0000002900000009/v1_201411150342/S2173580814001321/v1_201411150342/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173580814001321?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 18 | 2 | 20 |
2024 October | 345 | 24 | 369 |
2024 September | 452 | 32 | 484 |
2024 August | 393 | 16 | 409 |
2024 July | 391 | 16 | 407 |
2024 June | 252 | 8 | 260 |
2024 May | 256 | 13 | 269 |
2024 April | 329 | 12 | 341 |
2024 March | 393 | 14 | 407 |
2024 February | 398 | 14 | 412 |
2024 January | 355 | 16 | 371 |
2023 December | 256 | 10 | 266 |
2023 November | 295 | 16 | 311 |
2023 October | 260 | 15 | 275 |
2023 September | 204 | 17 | 221 |
2023 August | 94 | 6 | 100 |
2023 July | 99 | 8 | 107 |
2023 June | 96 | 12 | 108 |
2023 May | 152 | 14 | 166 |
2023 April | 119 | 8 | 127 |
2023 March | 112 | 8 | 120 |
2023 February | 85 | 15 | 100 |
2023 January | 83 | 12 | 95 |
2022 December | 74 | 19 | 93 |
2022 November | 71 | 12 | 83 |
2022 October | 75 | 27 | 102 |
2022 September | 51 | 37 | 88 |
2022 August | 47 | 11 | 58 |
2022 July | 50 | 18 | 68 |
2022 June | 25 | 17 | 42 |
2022 May | 25 | 13 | 38 |
2022 April | 29 | 7 | 36 |
2022 March | 86 | 17 | 103 |
2022 February | 39 | 15 | 54 |
2022 January | 72 | 9 | 81 |
2021 December | 38 | 17 | 55 |
2021 November | 42 | 11 | 53 |
2021 October | 15 | 22 | 37 |
2021 September | 20 | 17 | 37 |
2021 August | 24 | 12 | 36 |
2021 July | 22 | 11 | 33 |
2021 June | 17 | 10 | 27 |
2021 May | 46 | 19 | 65 |
2021 April | 115 | 50 | 165 |
2021 March | 75 | 53 | 128 |
2021 February | 55 | 18 | 73 |
2021 January | 31 | 17 | 48 |
2020 December | 21 | 15 | 36 |
2020 November | 16 | 7 | 23 |
2020 October | 28 | 19 | 47 |
2020 September | 21 | 14 | 35 |
2020 August | 21 | 8 | 29 |
2020 July | 39 | 20 | 59 |
2020 June | 19 | 12 | 31 |
2020 May | 208 | 20 | 228 |
2020 April | 40 | 13 | 53 |
2020 March | 37 | 11 | 48 |
2020 February | 35 | 10 | 45 |
2020 January | 26 | 5 | 31 |
2019 December | 35 | 6 | 41 |
2019 November | 17 | 13 | 30 |
2019 October | 49 | 18 | 67 |
2019 September | 51 | 17 | 68 |
2019 August | 21 | 8 | 29 |
2019 July | 29 | 10 | 39 |
2019 June | 55 | 54 | 109 |
2019 May | 88 | 46 | 134 |
2019 April | 52 | 22 | 74 |
2019 March | 36 | 16 | 52 |
2019 February | 36 | 21 | 57 |
2019 January | 27 | 20 | 47 |
2018 December | 23 | 15 | 38 |
2018 November | 31 | 19 | 50 |
2018 October | 54 | 38 | 92 |
2018 September | 40 | 17 | 57 |
2018 August | 15 | 16 | 31 |
2018 July | 12 | 7 | 19 |
2018 June | 13 | 11 | 24 |
2018 May | 14 | 13 | 27 |
2018 April | 17 | 11 | 28 |
2018 March | 28 | 11 | 39 |
2018 February | 21 | 10 | 31 |
2018 January | 19 | 14 | 33 |
2017 December | 13 | 14 | 27 |
2017 November | 24 | 7 | 31 |
2017 October | 35 | 16 | 51 |
2017 September | 22 | 8 | 30 |
2017 August | 28 | 8 | 36 |
2017 July | 22 | 12 | 34 |
2017 June | 34 | 15 | 49 |
2017 May | 30 | 25 | 55 |
2017 April | 20 | 18 | 38 |
2017 March | 18 | 23 | 41 |
2017 February | 25 | 9 | 34 |
2017 January | 38 | 13 | 51 |
2016 December | 32 | 14 | 46 |
2016 November | 42 | 13 | 55 |
2016 October | 34 | 10 | 44 |
2016 September | 34 | 16 | 50 |
2016 August | 30 | 10 | 40 |
2016 July | 32 | 8 | 40 |
2016 June | 39 | 10 | 49 |
2016 May | 18 | 19 | 37 |
2016 April | 33 | 33 | 66 |
2016 March | 30 | 37 | 67 |
2016 February | 33 | 25 | 58 |
2016 January | 24 | 23 | 47 |
2015 December | 26 | 21 | 47 |
2015 November | 47 | 27 | 74 |
2015 October | 47 | 37 | 84 |
2015 September | 38 | 34 | 72 |
2015 August | 40 | 30 | 70 |
2015 July | 36 | 6 | 42 |
2015 June | 28 | 14 | 42 |
2015 May | 87 | 36 | 123 |
2015 April | 51 | 42 | 93 |
2015 March | 65 | 37 | 102 |
2015 February | 94 | 40 | 134 |
2015 January | 111 | 38 | 149 |
2014 December | 97 | 35 | 132 |
2014 November | 64 | 33 | 97 |